Newsroom

According to a study led by Dr. Raül Andero, the drug Osanetant could reduce the intensity at which the fear memory is consolidated, thus preventing the onset of post-traumatic stress disorder (PTSD). The research, conducted with female mice, highlights important sex differences in fear processing.

A recent study led by Dr Assumpció Bosch demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC), even when treatment begins after symptom onset.

The event brought together 40 renowned researchers to advance science in Spain and foster collaborations.

On March 14th, UniStem Day 2025 took place, a special event dedicated to stem cells and advanced therapies for high school students.

We spoke with Dr. Alex Taylor, coordinator of the Animal Minds Lab, who told us about the focus of his research and what is currently known about animal intelligence.

On February 20th, 2025 took place the official launch of the DIPOLE project, a collaborative initiative aimed at advancing personalized treatment for pharmacoresistant epilepsies. 

This week, from March 10th to 16th, marks Brain Awareness Week, a global initiative aimed at sharing knowledge about this fascinating organ and the ongoing research to unravel its mysteries.

Professor Raul Andero’s laboratory, Translational Mechanisms of Fear Memory, has registered a European patent on the use of Fezolinetant—a drug originally developed to treat vasomotor symptoms associated with menopause—for modulating the consolidation of aversive memories.

Seventeen female researchers from the Institute have been recognized in the recent "Ranking of Spanish Women Researchers" published this February.

To commemorate February 11, the International Day of Women and Girls in Science, our Institute lanched several initiatives to give visibility to women scientists and inspire young girls to pursue scientific careers.